Trials / Not Yet Recruiting
Not Yet RecruitingNCT06962462
Daily Tadalafil in Diabetic ED Patients
Effect of Daily Tadalafil Therapy on Endothelin-1 and E-Selectin in Diabetic Patients With Erectile Dysfunction
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- South Valley University · Academic / Other
- Sex
- Male
- Age
- 30 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
This study evaluates the effect of 5 mg daily tadalafil therapy on serum levels of Endothelin-1 and E-selectin in diabetic male patients with erectile dysfunction. Outcomes will be compared pre- and post-treatment versus healthy controls.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Methyl Cellulose Placebo | Oral administration of inert methyl cellulose placebo tablets once daily for 3 months. Used as a comparator in healthy control participants to evaluate changes in Endothelin-1 and E-selectin serum levels. |
Timeline
- Start date
- 2025-05-05
- Primary completion
- 2025-08-05
- Completion
- 2025-08-30
- First posted
- 2025-05-08
- Last updated
- 2025-05-08
Source: ClinicalTrials.gov record NCT06962462. Inclusion in this directory is not an endorsement.